Most Recent
Fairfax denies defaming barrister in article linking him to ‘largest ever’ US tax fraud
Fairfax has hit back at claims in a lawsuit that the publisher defamed a barrister in an article alleging he helped Texas billionaire Bob Brockman defraud the United States of US$2 billion in taxes, denying the article defamed the lawyer and saying the report was an honest summary of publically available information.
Judge OKs $9.5M McMillan Shakespeare settlement despite funder, lawyers taking bulk
A judge has approved a $9.5 million settlement in a class action against McMillan Shakespeare as fair and reasonable, allowing a common fund order and a nearly 30 percent commission for the litigation funder despite previously raising "real concerns" about the small portion flowing to group members.
High Court soon to decide issue of competing class actions
In Wigmans v AMP the High Court will shortly deliver judgment on the vexed issue of class actions that compete to represent substantially the same class or group. Dr Michael Duffy of Monash University previews the decision.
Class action seeks to expand claims against PwC over Axsesstoday accounting lapses
Bondholders of Axsesstoday are seeking to expand their claims in a class action against the collapsed asset finance lender and its accountant PricewaterhouseCoopers, alleging PwC kept investors in the dark about a spike in the company's arrears ratio prior to issuing a $50 million bond prospectus.
Fairfax rejected settlement offers with ‘bugger off letters’, Elaine Stead tells court
Venture capitalist Dr Elaine Stead is seeking indemnity costs after being awarded $280,000 in her defamation case against Nine-owned Fairfax, which she accuses of rejecting several settlement offers with "bugger off letters" and engaging in a "petulant campaign" of media coverage post-judgment.
Death causes six-month delay of trial in Merck, Pfizer vaccine patent dispute
The Federal Court has delayed a 15-day hearing in a pneumococcal vaccine patent dispute between Merck Sharp & Dohme and Pfizer after the sudden death of a family member of one of Pfizer's expert witnesses.
J&J slammed for ‘wreckage’ of a case in pelvic mesh class action appeal
A group of women harmed by pelvic mesh devices produced by Johnson & Johnson have accused it of persisting with a "wreckage" of a case in which one of its own doctors admitted the pharmaceutical company knew of the risks posed by the implants at they time they were sold worldwide.
MySuper lawsuit gets one more chance before NAB pulls trigger on dismissal
Two NAB units have indicated they will seek to dismiss a lawsuit over alleged MySuper mismanagement which the court recently ruled was not validly commenced as a class action if the lead applicant fails in his bid to replead.
High Court rejects Westpac’s ‘gloss’ on financial product advice statute
The High Court has dismissed an appeal by Westpac challenging a ruling that found the bank breached its duties to customers by providing personal financial advice as part of a telephone campaign encouraging customers to roll over external superannuation accounts.
Chau Chak Wing awarded $590,000 in defamation case against ABC, Nine
Chinese businessman Dr Chau Chak Wing has been awarded $590,000 in a Federal Court judgment that found an ABC Four Corner's report contained "untrue and seriously defamatory imputations" about alleged espionage, bribery of UN leaders, and links to the Chinese Communist Party.